Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Net Income | -722 | -2,190 |
| Depreciation Amortization | 2 | 0 |
| Accounts payable and accrued liabilities | 207 | 0 |
| Other Working Capital | 198 | 40 |
| Other Operating Activity | -37 | 650 |
| Operating Cash Flow | $-352 | $-1,500 |
| Cash Flows From Investing Activities | ||
| PPE Investments | N/A | -2 |
| Investing Cash Flow | $N/A | $-2 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 501 | 0 |
| Other Financing Activity | 0 | 1,120 |
| Financing Cash Flow | $501 | $1,120 |
| Beginning Cash Position | 333 | 710 |
| End Cash Position | 481 | 330 |
| Net Cash Flow | $148 | $-380 |
| Free Cash Flow | ||
| Operating Cash Flow | -352 | -1,500 |
| Free Cash Flow | -352 | -1,500 |